Lab Head Pharmaceutical Characterization and Preformulation (Oral solid dosage forms)
Siegfried
About this role
Siegfried is seeking a visionary Lab Head Pharmaceutical Characterization and Preformulation to lead the development of new analytical and physico-chemical laboratories within a global CDMO environment. The role involves building, scaling, and defining advanced characterization capabilities to support innovative drug development processes across Switzerland and Spain.
Skills
Qualifications
About Siegfried
siegfried.chSiegfried is your trusted global CDMO partner. Offering development and manufacturing from early-phase to commercial, from drug substance to drug product.
Recent company news
Fierce PharmaUPDATE: Noramco divestment continues as it re-establishes CDMO Halo Pharma
1 month ago
C&ENSiegfried to get 2 new US sites with purchase of Noramco
1 month ago
BerkeleysideRemembering Siegfried Brockmann, who escaped from East Germany in 1948 and became a VP at Cole Chemical Company
Jan 6, 2026
Business WireSK Capital Partners Announces Agreement to Sell Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
1 month ago
PR NewswireSiegfried expands national presence with addition of a Dallas-Fort Worth Market
Jul 29, 2025
About Siegfried
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Siegfried.
Salary
$12k – $16k
per year
More jobs at Siegfried
Similar Jobs
Associate Scientist II - Chemical Characterization
Baxter International
M&S-QC Analyst Physico Chemistry-Beijing
Sanofi
Senior Scientist Quality Control (m/f/d) 80-100%
WayUp
Director, Analytical Chemistry Extended Characterization
Eli Lilly and Company
Campus Internship 2025-2026 - R&D Characterization
DOW BRASIL SUDESTE INDUSTRIAL LTDA
Senior Director, Head of Extended Characterization US
GSK plc